User profiles for Yohei Doi

Yohei Doi

University of Pittsburgh
Verified email at pitt.edu
Cited by 35351

Treatment options for carbapenem-resistant gram-negative bacterial infections

Y Doi - Clinical Infectious Diseases, 2019 - academic.oup.com
Antimicrobial resistance has become one of the greatest threats to public health, with rising
resistance to carbapenems being a particular concern due to the lack of effective and safe …

Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae

…, RC Kalayjian, RR Watkins, Y Doi… - Clinical Infectious …, 2018 - academic.oup.com
Background The efficacy of ceftazidime-avibactam—a cephalosporin–β-lactamase inhibitor
combination with in vitro activity against Klebsiella pneumoniae carbapenemase–producing …

Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance

…, AW Pasculle, RK Ernst, Y Doi - Clinical infectious …, 2015 - academic.oup.com
Background. With an increase in the use of colistin methansulfonate (CMS) to treat
carbapenem-resistant Acinetobacter baumannii infections, colistin resistance is emerging. Methods. …

[HTML][HTML] Carbapenemase-producing enterobacteriaceae

Y Doi, DL Paterson - Seminars in respiratory and critical care …, 2015 - thieme-connect.com
Carbapenemase-producing Enterobacteriaceae (CPE) were almost nonexistent up to the
1990s, but are today encountered routinely in hospitals and other healthcare facilities in many …

The global epidemiology of carbapenemase-producing Enterobacteriaceae

D van Duin, Y Doi - Virulence, 2017 - Taylor & Francis
Carbapenemase-producing Enterobacteriaceae (CPE) are an important and increasing threat
to global health. Both clonal spread and plasmid-mediated transmission contribute to the …

Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)

…, LL Zhong, C Shen, Y Yang, Y Doi… - Emerging microbes & …, 2020 - Taylor & Francis
Increasing antibiotic resistance in multidrug-resistant (MDR) Gram-negative bacteria (MDR-GNB)
presents significant health problems worldwide, since the vital available and effective …

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study

…, LX Yi, R Zhang, J Spencer, Y Doi… - The Lancet infectious …, 2016 - thelancet.com
Background Until now, polymyxin resistance has involved chromosomal mutations but has
never been reported via horizontal gene transfer. During a routine surveillance project on …

Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE …

…, R Echols, Y Matsunaga, M Ariyasu, Y Doi… - The Lancet infectious …, 2021 - thelancet.com
Background New antibiotics are needed for the treatment of patients with life-threatening
carbapenem-resistant Gram-negative infections. We assessed the efficacy and safety of …

16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides

Y Doi, Y Arakawa - Clinical Infectious Diseases, 2007 - academic.oup.com
Methylation of 16S ribosomal RNA (rRNA) has recently emerged as a new mechanism of
resistance against aminoglycosides among gram-negative pathogens belonging to the family …

Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens

…, B Polsky, JM Adams-Haduch, Y Doi - Antimicrobial agents …, 2012 - Am Soc Microbiol
Klebsiella pneumoniae producing Klebsiella pneumoniae carbapenemase (KPC) has been
associated with serious infections and high mortality. The optimal antimicrobial therapy for …